Literature DB >> 25911821

[Studies on effects of calycosin-7-O-β-D-glucoside on prim-O-glucosylcimifugin and cimifugin in vivo pharmacokinetics].

Xiao-Li Zhao, Ling Liu, Liu-Qing Di, Jun-Song Li, An Kang.   

Abstract

Study on the effects of Astragali Radix main active flavone calycosin-7-O-β-D-glucoside on Saposhnikoviae Radix main active ingredients prim-O-glucosylcimifugin and cimifugin, a UPLC-MS/MS method for simultaneous determination of prim-O-glucosylcimifugin and cimifugin in rat plasma was established, and the comparative pharmacokinetics of prim-O-glucosylcimifugin and cimifugin after oral administration of prim-O-glucosylcimifugin and calycosin-7-O-β-D-glucoside-prim-O-glucosylcimifugin to rats were carried out, which might be conductive in exploring the rationality of Astragali Radix - Saposhnikoviae Radix herb couple. Twelve male SD rats were divided into two groups. Prim-O-glucosylcimifugin and cimifugin in rat plasma of different time points after oral administration of prim-O-glucosylcimifugin and calycosin-7-O-β-D-glucoside - prim-O-glucosylcimifugin to rats were determinated. And the main pharmacokinetic parameters were investigated using DAS 3. 2. 4. The established method was rapid, accurate and sensitive for simultaneous determination of prim-O-glucosylcimifugin and cimifugin in rat plasma. The analysis was performed on a Waters Acquity BEH C18 column (2.1 mm x 100 mm, 1.7 μm) with the mixture of acetonitrile and 0.1% formic acid/water as mobile phase, and the gradient elution at a flow rate of 0.3 mL x min(-1). The analytes were detected by tandem mass spectrometry with the electrospray ionization (ESI) source and in the multiple reaction monitoring (MRM) mode. Compared with prim-O-glucosylcimifugin group, the AUC(0-t)., and AUC(0-∞) of p-O-glucosylcimifugin as well as the C(max) of cimifugin significantly increased (P < 0.05) in calycosin-7-O-β-D-glucoside-prim-O-glucosylcimifugin group. Calycosin-7-O-β-D-glucoside could enhance the absorption of prim-O-glucosylcimifugin and cimifugin and improve the bioavailability, explaining preliminarily the rationality of Astragali Radix-Saposhnikoviae Radix herb couple.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25911821

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  5 in total

1.  Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions.

Authors:  Xiaoyu Wang; Xiaoyan Jiang; Xi Yu; Hailiang Liu; Yu Tao; Guorong Jiang; Min Hong
Journal:  J Cell Mol Med       Date:  2017-06-09       Impact factor: 5.310

2.  Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways.

Authors:  Wenwen Yang; Linwensi Zhu; Shanglei Lai; Qinchao Ding; Tiantian Xu; Rui Guo; Xiaobing Dou; Hui Chai; Zhiling Yu; Songtao Li
Journal:  Oxid Med Cell Longev       Date:  2022-03-20       Impact factor: 6.543

3.  Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.

Authors:  Aimin Liu; Wei Zhao; Buxin Zhang; Yuanhui Tu; Qingxing Wang; Jing Li
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

4.  Calycosin alleviates allergic contact dermatitis by repairing epithelial tight junctions via down-regulating HIF-1α.

Authors:  Zhirong Jia; Xiaotong Wang; Xiaoyu Wang; Pan Wei; Lianqu Li; Peng Wu; Min Hong
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310

5.  Simultaneous determination of calycosin, prim-O-glucosylcimifugin, and paeoniflorin in rat plasma by HPLC-MS/MS: application in the pharmacokinetic analysis of HQCF.

Authors:  Yulong Gu; Xianglan Piao; Dan Zhu
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.